Compare MDGL & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDGL | EQH |
|---|---|---|
| Founded | 2011 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 13.3B |
| IPO Year | 2005 | 2017 |
| Metric | MDGL | EQH |
|---|---|---|
| Price | $499.71 | $51.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 12 |
| Target Price | ★ $682.11 | $62.09 |
| AVG Volume (30 Days) | 188.1K | ★ 2.5M |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.50 |
| Revenue | $180,133,000.00 | ★ $11,665,000,000.00 |
| Revenue This Year | $59.37 | $32.53 |
| Revenue Next Year | $39.35 | $11.49 |
| P/E Ratio | ★ N/A | $104.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $393.61 | $35.20 |
| 52 Week High | $615.00 | $55.06 |
| Indicator | MDGL | EQH |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 43.96 |
| Support Level | $501.44 | $47.00 |
| Resistance Level | $543.75 | $53.32 |
| Average True Range (ATR) | 15.08 | 1.29 |
| MACD | -2.69 | -0.37 |
| Stochastic Oscillator | 18.82 | 1.71 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.